Preoperative MRI Features Associated With Lymphovascular Invasion in Node-Negative Invasive Breast Cancer: A Propensity-Matched Analysis

被引:48
作者
Cheon, Hyejin [1 ]
Kim, Hye Jung [1 ]
Lee, So Mi [1 ]
Cho, Seung Hyun [1 ]
Shin, Kyung Min [1 ]
Kim, Gab Chul [1 ]
Park, Ji Young [2 ]
Kim, Won Hwa [1 ]
机构
[1] Kyungpook Natl Univ, Med Ctr, Dept Radiol, 807 Hoguk Ro, Daegu 41404, South Korea
[2] Kyungpook Natl Univ, Med Ctr, Dept Pathol, Daegu, South Korea
关键词
SENTINEL LYMPH-NODE; NEOADJUVANT CHEMOTHERAPY; HISTOPATHOLOGIC FINDINGS; PERIPHERAL ENHANCEMENT; AXILLARY DISSECTION; TUMOR ANGIOGENESIS; PERITUMORAL EDEMA; PREPECTORAL EDEMA; IMAGING FEATURES; PROGNOSTIC VALUE;
D O I
10.1002/jmri.25710
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: In node-negative disease, the presence of lymphovascular invasion (LVI) is reported to be an unfavorable prognostic factor. Thus, the aim of this study was to evaluate whether preoperative breast MRI features are associated with LVI in patients with node-negative invasive breast cancer by a propensity-matched analysis. Materials and Methods: Among 389 patients with node-negative invasive ductal breast cancer who had preoperative breast 3.0 Tesla MRI with precontrast T2-weighted fat-suppressed, pre- and dynamic postcontrast T1-weighted fat-suppressed sequences, 61 patients with LVI (LVI group) were matched with 183 patients without LVI (no LVI group) at a ratio of 1:3 in terms of age, histologic grade, tumor size, and hormone receptor status. Two radiologists reviewed the MRI features, following profiles of focal breast edema (peritumoral, prepectoral, subcutaneous), intratumoral T2 signal intensity, adjacent vessel sign, and increased ipsilateral whole-breast vascularity, in addition to 2013 Breast Imaging Reporting and Data System lexicon. Results: The presence of peritumoral edema (45.9% [28/61] versus 30.6% [56/183], P=0.030) and adjacent vessel sign (82.0% [50/61] versus 68.3% [125/183], P=0.041) was significantly associated with LVI. Prepectoral edema was also more frequently observed in the LVI group than in the no LVI group with borderline significance (26.2% [16/61] versus 15.3% [28/183], P=0.055). In cases of nonmass enhancement, regional enhancement was more frequently found in the LVI group than in the no LVI group (60.0% [3/4] versus 5.9% [1/4], P=0.042). Conclusion: Preoperative breast MRI features may be associated with LVI in patients with node-negative invasive breast cancer.
引用
收藏
页码:1037 / 1044
页数:8
相关论文
共 41 条
  • [31] Can T2-weighted 3-T breast MRI predict clinically occult inflammatory breast cancer before pathological examination? A single-center experience
    Uematsu, Takayoshi
    Kasami, Masako
    Watanabe, Junichiro
    [J]. BREAST CANCER, 2014, 21 (01) : 115 - 121
  • [32] MRI findings of inflammatory breast cancer, locally advanced breast cancer, and acute mastitis: T2-weighted images can increase the specificity of inflammatory breast cancer
    Uematsu, Takayoshi
    [J]. BREAST CANCER, 2012, 19 (04) : 289 - 294
  • [33] Estrogen Receptor, Progesterone Receptor, and HER2 Status Predict Lymphovascular Invasion and Lymph Node Involvement
    Ugras, Stacy
    Stempel, Michelle
    Patil, Sujata
    Morrow, Monica
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (12) : 3780 - 3786
  • [34] Enhancing area surrounding breast carcinoma on MR mammography: comparison with pathological examination
    Van Goethem, M
    Schelfout, K
    Kersschot, E
    Colpaert, C
    Verslegers, I
    Biltjes, I
    Tjalma, WA
    Weyler, J
    [J]. EUROPEAN RADIOLOGY, 2004, 14 (08) : 1363 - 1370
  • [35] A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy
    Van Zee, KJ
    Manasseh, DME
    Bevilacqua, JLB
    Boolbol, SK
    Fey, JV
    Tan, LK
    Borgen, PI
    Cody, HS
    Kattan, MW
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (10) : 1140 - 1151
  • [36] Sentinel lymph node biopsy and axillary dissection in breast cancer: Results in a large series
    Veronesi, U
    Paganelli, G
    Viale, G
    Galimberti, V
    Luini, A
    Zurrida, S
    Robertson, C
    Sacchini, V
    Veronesi, P
    Orvieto, E
    De Cicco, C
    Intra, M
    Tosi, G
    Scarpa, D
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (04): : 368 - 373
  • [37] Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes
    Veronesi, U
    Paganelli, G
    Galimberti, V
    Viale, G
    Zurrida, S
    Bedoni, M
    Costa, A
    deCicco, C
    Geraghty, JG
    Luini, A
    Sacchini, V
    Veronesi, P
    [J]. LANCET, 1997, 349 (9069) : 1864 - 1867
  • [38] Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: Pooled results of two large European randomized trials
    Voogd, AC
    Nielsen, M
    Peterse, JL
    Blichert-Toft, M
    Bartelink, H
    Overgaard, M
    van Tienhoven, G
    Andersen, KW
    Sylvester, RJ
    van Dongen, JA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (06) : 1688 - 1697
  • [39] Weiser MR, 2001, ANN SURG ONCOL, V8, P145, DOI 10.1245/aso.2001.8.2.145
  • [40] Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI [10.1200/JCO.2013.50.9984, 10.5858/arpa.2013-0953-SA]